Immune responses to liver-stage parasites: implications for vaccine development.
Hollingdale
Michael R
MR
London School of Hygiene and Tropical Medicine, Department of Infectious and Tropical Diseases, London, UK. Michael.Hollingdale@lshtm.ac.uk
Krzych
Urszula
U
D000276:Adjuvants, Immunologic; D000818:Animals; D000913:Antibodies, Protozoan / Q000096:biosynthesis / Q000276:immunology; D000918:Antibody Specificity; D000953:Antigens, Protozoan / Q000276:immunology; D002986:Clinical Trials as Topic; D004198:Disease Susceptibility; D006680:HLA Antigens / Q000235:genetics / Q000276:immunology; D006790:Host-Parasite Interactions / Q000276:immunology; D006801:Humans; D007113:Immunity, Innate; D007114:Immunization / Q000379:methods; D008099:Liver / Q000469:parasitology*; D008288:Malaria / Q000276:immunology* / Q000469:parasitology / Q000517:prevention & control; D017780:Malaria Vaccines / Q000276:immunology*; D051379:Mice; D010961:Plasmodium / Q000254:growth & development / Q000276:immunology*; D010962:Plasmodium berghei / Q000276:immunology; D011323:Primates / Q000276:immunology; D015800:Protozoan Proteins / Q000276:immunology; D011948:Receptors, Antigen, T-Cell / Q000235:genetics / Q000276:immunology
D000276:Adjuvants, Immunologic; D000913:Antibodies, Protozoan; D000953:Antigens, Protozoan; D006680:HLA Antigens; D017780:Malaria Vaccines; D015800:Protozoan Proteins; D011948:Receptors, Antigen, T-Cell